N
PAVM icon

Nuveen’s PAVmed PAVM Stock Holding History

Nuveen’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,295
Closed -$874K – 3430
2022
Q1 		$874K Sell
1,295
-315
-20% -$234K ﹤0.01% 2858
2021
Q4 		$2.07M Sell
1,610
-269
-14% -$585K ﹤0.01% 2549
2021
Q3 		$6.88M Sell
1,879
-835
-31% -$2.63M ﹤0.01% 2040
2021
Q2 		$7.82M Buy
2,714
+2,245
+479% +$5.3M ﹤0.01% 2008
2021
Q1 		$937K Buy
469
+61
+15% +$91.7K ﹤0.01% 2906
2020
Q4 		$389K Sell
408
-2
-0.5% -$1.71K ﹤0.01% 3095
2020
Q3 		$328K Hold
410
– – ﹤0.01% 3064
2020
Q2 		$389K Buy
+410
New +$410K ﹤0.01% 2985

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen's PAVM Position: Q2 2022 in Review

Nuveen sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 1,295 shares — an estimated $874K sold.

Nuveen first reported a position in PAVM in Q2 2020 and held it in 8 quarters. The position peaked at $7.82M in Q2 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • Nuveen reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 1,295 PAVmed shares in Q2 2022, an estimated $874K.
  • Nuveen first reported a position in PAVmed in Q2 2020 and held it in 8 quarters.
  • Nuveen's PAVmed position peaked at $7.82M in Q2 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.